209 related articles for article (PubMed ID: 29200014)
1. Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.
Piechotta PL; Bonekamp D; Sill M; Wick A; Wick W; Bendszus M; Kickingereder P
Invest Radiol; 2018 Apr; 53(4):223-228. PubMed ID: 29200014
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
3. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Jayachandran Preetha C; Meredig H; Brugnara G; Mahmutoglu MA; Foltyn M; Isensee F; Kessler T; Pflüger I; Schell M; Neuberger U; Petersen J; Wick A; Heiland S; Debus J; Platten M; Idbaih A; Brandes AA; Winkler F; van den Bent MJ; Nabors B; Stupp R; Maier-Hein KH; Gorlia T; Tonn JC; Weller M; Wick W; Bendszus M; Vollmuth P
Lancet Digit Health; 2021 Dec; 3(12):e784-e794. PubMed ID: 34688602
[TBL] [Abstract][Full Text] [Related]
4. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
[TBL] [Abstract][Full Text] [Related]
5. Application of Synthetic MRI for Direct Measurement of Magnetic Resonance Relaxation Time and Tumor Volume at Multiple Time Points after Contrast Administration: Preliminary Results in Patients with Brain Metastasis.
Kang KM; Choi SH; Hwang M; Yoo RE; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2018; 19(4):783-791. PubMed ID: 29962885
[TBL] [Abstract][Full Text] [Related]
6. Is systematic Gadolinium injection relevant during MRI follow-up for non-functioning pituitary macroadenomas?
Villemaire A; Adam G; Fayolle H; Roques M; Darcourt J; Caron P; Bonneville F
J Neuroradiol; 2023 Feb; 50(1):3-8. PubMed ID: 36055429
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
8. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.
Kleesiek J; Morshuis JN; Isensee F; Deike-Hofmann K; Paech D; Kickingereder P; Köthe U; Rother C; Forsting M; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2019 Oct; 54(10):653-660. PubMed ID: 31261293
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
[TBL] [Abstract][Full Text] [Related]
11. Consecutive acquisition of time-resolved contrast-enhanced MR angiography and perfusion MR imaging with added dose of gadolinium-based contrast agent aids diagnosis of suspected brain metastasis.
Tsuchiya K; Aoki S; Shimoji K; Mori H; Kunimatsu A
Magn Reson Med Sci; 2013; 12(2):87-93. PubMed ID: 23666159
[TBL] [Abstract][Full Text] [Related]
12. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
Zhou ZR; Shen TZ; Chen XR; Peng WJ
Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium contrast medium administration does not adversely affect T2*-weighted gradient recalled echo magnetic resonance imaging of the canine brain at 1.5 Tesla.
Bartels J; Hecht S; Conklin GA; Xiaocun S
Vet Radiol Ultrasound; 2019 Mar; 60(2):184-191. PubMed ID: 30159943
[TBL] [Abstract][Full Text] [Related]
15. Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.
Rovira A; Auger C; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Tintoré M; Montalban X
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1486-1493. PubMed ID: 28619842
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
[TBL] [Abstract][Full Text] [Related]
17. Comparing genomic and histologic correlations to radiographic changes in tumors: a murine SCC VII model study.
Yang YS; Guccione S; Bednarski MD
Acad Radiol; 2003 Oct; 10(10):1165-75. PubMed ID: 14587635
[TBL] [Abstract][Full Text] [Related]
18. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
19. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging.
Bauknecht HC; Romano VC; Rogalla P; Klingebiel R; Wolf C; Bornemann L; Hamm B; Hein PA
Invest Radiol; 2010 Jan; 45(1):49-56. PubMed ID: 19996757
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
